Comparative analysis of the effects of resveratrol in two apoptotic models:: Inhibition of complex I and potassium deprivation in cerebellar neurons

被引:80
作者
Alvira, D.
Yeste-Velasco, M.
Folch, J.
Verdaguer, E.
Canudas, A. M.
Pallas, M.
Camins, A.
机构
[1] Univ Barcelona, Fac Farm, Unitat Farmacol Farmacognosia, E-08028 Barcelona, Spain
[2] Univ Rovira & Virgili, Fac Med Ciencies Salut, Unitat Bioquim, Tarragona 43201, Spain
[3] Univ Barcelona, Fac Farm, Inst Biomed, E-08028 Barcelona, Spain
[4] CSIC, Dept Farmacol & Toxicol, IIBB, IDIBAPS, Barcelona 08036, Spain
关键词
cerebellar granule cells; resveratrol; sirtinol; SIRT1; MPP; serum and potassium withdrawal;
D O I
10.1016/j.neuroscience.2007.04.029
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The mechanism involved in neuronal apoptosis is largely unknown. Studies performed on neuronal cell cultures provide information about the pathways which orchestrate the process of neuronal loss and potential drugs for the treatment of neurological disorders. In the present study we select resveratrol, a natural antioxidant, as a potential drug for the treatment of neurodegenerative diseases. We evaluate the neuroprotective effects of resveratrol in two apoptotic models in rat cerebellar granule neurons (CGNs): the inhibition of mitochondrial complex I using 1-methyl-4-phenylpyridinium (MPP+) (an in vitro model of Parkinson's disease) and serum potassium withdrawal. We study the role of the mammalian silent information regulator 2 (SIRT1) in the process of neuroprotection mediated by resveratrol. Because recent studies have demonstrated that SIRT1 is involved in cell survival and has antiaging properties, we also measured changes in the expression of this protein after the addition of these two apoptotic stimuli. MPP+-induced loss of cell viability and apoptosis in CGNs was prevented by the addition of RESV (1 mu M to 100 mu M). However, the neuroprotective effects were not mediated by the activation of SIRT1, since sirtinol - an inhibitor of this enzyme-did not attenuate them. Furthermore MPP+ decreases the protein expression of SIRT1. RESV did not prevent serum potassium withdrawal-induced apoptosis although it did completely attenuate oxidative stress production by these apoptotic stimuli. Furthermore, serum potassium withdrawal increases the expression of SIRT1. Our results indicate that the antiapoptotic effects of RESV in MPP+ are independent of the stimulation of SIRT1 and depend on its antioxidant properties. Furthermore, because SIRT1 is involved in neuronal survival depending on the apoptotic stimuli, changes in the expression of SIRT1 could be involved in the regulation of the apoptotic route. (C) 2007 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:746 / 756
页数:11
相关论文
共 47 条
  • [1] Resveratrol - A boon for treating Alzheimer's disease?
    Anekonda, Thimmappa S.
    [J]. BRAIN RESEARCH REVIEWS, 2006, 52 (02) : 316 - 326
  • [2] Neuronal protection by sirtuins in Alzheimer's disease
    Anekonda, TS
    Reddy, PH
    [J]. JOURNAL OF NEUROCHEMISTRY, 2006, 96 (02) : 305 - 313
  • [3] Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration
    Araki, T
    Sasaki, Y
    Milbrandt, J
    [J]. SCIENCE, 2004, 305 (5686) : 1010 - 1013
  • [4] Neuroprotection by resveratrol against traumatic brain injury in rats
    Ates, Ozkan
    Cayli, Suleyman
    Altinoz, Eyup
    Gurses, Iclal
    Yucel, Neslihan
    Sener, Metin
    Kocak, Ayhan
    Yologlu, Saim
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2007, 294 (1-2) : 137 - 144
  • [5] Natural extracts as possible protective agents of brain aging
    Bastianetto, S
    Quirion, R
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (05) : 891 - 897
  • [6] Therapeutic potential of resveratrol:: the in vivo evidence
    Baur, Joseph A.
    Sinclair, David A.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) : 493 - 506
  • [7] SIRT1 protects against microglia-dependent amyloid-β toxicity through inhibiting NF-κB signaling
    Chen, J
    Zhou, YG
    Mueller-Steiner, S
    Chen, LF
    Kwon, H
    Yi, SL
    Mucke, L
    Li, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (48) : 40364 - 40374
  • [8] Apoptosis inducing factor mediates caspase-independent 1-methyl-4-phenylpyridinium toxicity in dopaminergic cells
    Chu, CT
    Zhu, J
    Cao, GD
    Signore, A
    Wang, SP
    Chen, J
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 94 (06) : 1685 - 1695
  • [9] Nutritional antioxidants as antidegenerative agents
    De Ruvo, C
    Amodio, R
    Algeri, S
    Martelli, N
    Intilangelo, A
    D'Ancona, GM
    Esposito, E
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2000, 18 (4-5) : 359 - 366
  • [10] p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism
    Duan, WZ
    Zhu, XX
    Ladenheim, B
    Yu, QS
    Guo, ZH
    Oyler, J
    Cutler, RG
    Cadet, JL
    Greig, NH
    Mattson, MP
    [J]. ANNALS OF NEUROLOGY, 2002, 52 (05) : 597 - 606